Decoding In Vitro Oncology Innovations: Organoids, OMICs, and Their Role in Early Cancer Drug Discovery

Researchers are faced with challenges in translating preclinical cancer research into successful clinical outcomes.

This white paper explores ways that 3D organoid models and integrated OMICs approaches can bridge the gap and improve the predictability of early-stage drug development. Download now to learn more about organoids replicating patient-specific tumor environments; the use of genomics, transcriptomics, and proteomics in developing predictive biomarkers; strategies to reduce the high attrition rates of oncology drug candidates; and more.